<SEC-DOCUMENT>0001640334-18-000936-index.html : 20180511 <SEC-HEADER>0001640334-18-000936.hdr.sgml : 20180511 <ACCEPTANCE-DATETIME>20180511162247 ACCESSION NUMBER: 0001640334-18-000936 CONFORMED SUBMISSION TYPE: 20-F/A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20180511 DATE AS OF CHANGE: 20180511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-12033 FILM NUMBER: 18827193 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 </SEC-HEADER> <DOCUMENT> <TYPE>20-F/A <SEQUENCE>1 <FILENAME>nymox_20fa.htm <DESCRIPTION>FORM 20-F AMENDMENT NO. 1 <TEXT> Document 1 - file: nymox_20fa.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-12.A <SEQUENCE>2 <FILENAME>nymox_ex12b.htm <DESCRIPTION>CERTIFICATION <TEXT> Document 2 - file: nymox_ex12b.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-12.B <SEQUENCE>3 <FILENAME>nymox_ex12a.htm <DESCRIPTION>CERTIFICATION <TEXT> Document 3 - file: nymox_ex12a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-13.A <SEQUENCE>4 <FILENAME>nymox_ex13a.htm <DESCRIPTION>CERTIFICATION <TEXT> Document 4 - file: nymox_ex13a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-13.B <SEQUENCE>5 <FILENAME>nymox_ex13b.htm <DESCRIPTION>CERTIFICATION <TEXT> Document 5 - file: nymox_ex13b.htm
</DOCUMENT> </SEC-DOCUMENT>